Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05844475 · ClinicalTrials.gov registry record · NA

Buccal Graft + Collagen Matrix Versus Free Gingival Graft for Keratinized Mucosa Augmentation at Implant Sites

A NA study of Surgery, sponsored by Harvard Medical School (HMS and HSDM).

Active
Registry status
NA
Development phase
32
Enrollment target
1
Study location

NCT05844475 is a NA study of Surgery that is active but no longer recruiting, run by Harvard Medical School (HMS and HSDM). The registered enrollment target is 32 participants, below the 52,851-participant average among 120 other Surgery trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05844475, a NA study of Surgery, is active but no longer recruiting, sponsored by Harvard Medical School (HMS and HSDM).

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
32 participants
Enrollment target
1
Study location

Study Summary

The study aims at comparing two different approaches for soft tissue augmentation at implants lacking keratinized and adherent mucosa width: the free gingival graft (FGG) vs the Buccal Strip Graft in combination with a xenogeneic collagen matrix (BSG + CM)

Conditions Studied

Interventions

  • PROCEDURE Conventional Free Gingival Graft Approach (FGG)
  • PROCEDURE Buccal Strip Graft with a collagen matrix (bSG + CM)

Study Locations (1)

Massachusetts

  • Harvard School of Dental Medicine - Boston

Trial Details

FieldValue
Enrollment Target 32 participants
Start Date 2023-04-13
Est. Completion 2025-12-21
Phase NA

What the Registry Record Tells You About NCT05844475

The ClinicalTrials.gov registry entry for NCT05844475 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 52,851-participant average among 120 other Surgery trials with a reported enrollment target (100% lower). The listed sponsor is Harvard Medical School (HMS and HSDM), which has 26 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Surgery appearing as the primary indexed condition, and to 2 interventions - of which Conventional Free Gingival Graft Approach (FGG) is the first listed.

NCT05844475 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT05844475 about?

NCT05844475 is a clinical study titled "Buccal Graft + Collagen Matrix Versus Free Gingival Graft for Keratinized Mucosa Augmentation at Implant Sites". The study aims at comparing two different approaches for soft tissue augmentation at implants lacking keratinized and adherent mucosa width: the free gingival graft (FGG) vs the Buccal Strip Graft in combination with a xenogeneic collagen matrix (BSG + CM)

What is the current status of trial NCT05844475?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 32 participants. The study started on 2023-04-13. Estimated completion is 2025-12-21.

What conditions does trial NCT05844475 study?

This clinical trial studies the following conditions: Surgery.

What interventions are being tested in trial NCT05844475?

The interventions under investigation include: Conventional Free Gingival Graft Approach (FGG) (PROCEDURE), Buccal Strip Graft with a collagen matrix (bSG + CM) (PROCEDURE).

Who is sponsoring clinical trial NCT05844475?

This trial is sponsored by Harvard Medical School (HMS and HSDM), which has 26 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05844475 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Surgery

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.